KELSEY MASON: Open Payments
NPI 1134551641 · PLYMOUTH, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,075 in 122 payments from 18 companies in 2025. Trend: 2023 $1,439 · 2024 $2,410 · 2025 $2,075
Food & beverage: $1,924Education: $151
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $339 |
| Galderma Laboratories, L.P. | 17 | $186 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $184 |
| Regeneron Healthcare Solutions, Inc. | 4 | $173 |
| GENZYME CORPORATION | 9 | $149 |
| LEO Pharma Inc. | 11 | $145 |
| Lilly USA, LLC | 12 | $139 |
| Janssen Biotech, Inc. | 11 | $135 |
| Novartis Pharmaceuticals Corporation | 4 | $122 |
| Organon LLC | 12 | $117 |
Products named: SKYRIZI, NEMLUVIO, DUPIXENT, TREMFYA, ADBRY, RINVOQ, Bimzelx, OPZELURA.
Industry payments across MN — which companies pay providers there.
